Mechanism

Short peptide gene-expression modulation

Proposed modulation of gene expression by very short synthetic peptides.

Use only with conservative confidence for Khavinson-style short peptides.

Biological pathway

Some short-peptide studies report interactions with chromatin, DNA-associated proteins or transcriptional programmes in cell and animal models.

00b

Published evidence is predominantly laboratory, animal or small regional clinical literature.

00c

Mechanistic claims are not independently established at therapeutic scale, and product identity, dose and clinical relevance remain uncertain.

A synthetic dipeptide promoted for immune, thymic and healthy-ageing effects, supported mainly by preclinical and regional literature.

A synthetic Lys-Glu-Asp tripeptide promoted for vascular bioregulation, with limited and regionally concentrated evidence.

↳

from the knowledge graph

Peptides that touch this

Conditions in scope